About this trial
The goal of this study/research is to assess the relationship between ultrasound features of the myometrium suggestive of adenomyosis and clinical symptoms of adenomyosis and to establish a reporting system for adenomyosis assessing disease severity. Consecutive pre- and perimenopausal symptomatic and asymptomicasymptomatic women with an uterus presenting for gynaecological ultrasound exams will be asked to participate in the study. Routine gynecologicalgynaecological ultrasound exams will be performed and study participants will fill out a questionnaire on their symptoms (if any) and bleeding pattern. There will be one visit and no interventions.
Eligibility criteria
Qualifiers
Women of pre- and perimenopausal age presenting for gynaecologic ultrasound exam giving voluntary informed written consent.
Symptomatic and asymptomatic women
Patients with hormonal contraceptives and Hormone Replacement Therapy (HRT) can be included, but information will be noted.
Disqualifiers
Missing written consent (study consent)
Any serious underlying medical, psychiatric or psychological condition, which may interfere with the patient's capacity of discernment.
Postmenopausal women
Pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Swiss GO Trial Group
Lead sponsor
University Hospital, Basel, Switzerland
Collaborator